drugset / Trial / NCT03107416
Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of Bumetanide , at different doses to find out what effects, if any, it has on people who undergo tumor TAE as part of their regular care. Bumetanide is a commonly used medication to reduce the amount of water in the body.
Timeline
- Start
- 2017-04-05
- Primary completion
- 2027-04-05
- Completion
- 2027-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bumetanide | Small molecule | 0.01 mg/kg | Other |
| Subject | Bumetanide | Small molecule | 0.02 mg/kg | Other |
| Subject | Bumetanide | Small molecule | 0.04 mg/kg | Other |